Table 3.

Metabolome differences between cachectic patients with weight loss (WL) vs. stable weight (WS)

		Estimated mean value WS/WL a	95% CI of mean value diff.	P‐value	q‐Value
Alanine	DBS	0.379/−0.715	0.163–2.02	0.0252	0.3688
Alanine	Plasma	0.378/−0.562	0.173–1.71	0.0204	0.5137
Tryptophan	Plasma	0.593/−0.625	0.0819–2.36	0.0378	0.5137
3‐Methylglutaylcarnitine	Plasma	0.921/−0.438	0.00536–2.71	0.0493	0.5137
Ornithine	Plasma	1.44/0.607	0.0488–1.63	0.0392	0.5137
C16OH	Plasma	0.0485/1.05	−1.91 to −0.0897	0.0347	0.5137
C18	Plasma	0.933/−0.675	0.0683–3.15	0.0430	0.5137
C201	DBS	−0.924/0.479	−2.32 to −0.49	0.0064	0.1559
C6DC	Plasma	0.922/−0.453	0.0286–2.72	0.0461	0.5137
Q14	DBS	−1.06/0.288	−2.27 to −0.417	0.0097	0.1767
Q2	DBS	−0.404/1.37	−2.66 to −0.879	0.0013	0.0459
Q3	DBS	−0.0879/1.6	−2.45 to −0.919	0.0007	0.0459

Results are given according to binary categorization of weight loss from baseline (TP1) to the second (TP2) scheduled evaluation (Welch's two‐sided t‐test), n = 14. Only results with P‐value < 0.05 are reported. q‐Values represent results following correction for multiple testing.

95% CI, 95% C.I., 95% confidence interval; diff., difference; WL, weight loss; WS, weight stable.

^a Values represent SD.